Library
  • Behind the Science
  • Science Innovation
    • Vapor
    • Modern Oral
    • Traditional Oral
  • Scientific Assessment
    • Emission Studies
    • Exposure Studies
    • Risk Studies
  • Science Engagement & Communication
    • Publications
    • Conferences
    • Our Scientists
  • Library
  • Behind the Science
  • Science Innovation
    • Vapor
    • Modern Oral
    • Traditional Oral
  • Scientific Assessment
    • Emission Studies
    • Exposure Studies
    • Risk Studies
  • Science Engagement & Communication
    • Publications
    • Conferences
    • Our Scientists
  • Library

Archives: Conference

Distinguishing Tobacco-Derived Nicotine from Synthetic Nicotine in Commercial Nicotine Samples

November 18, 2022

By Cole Gibson

Genotoxicity Assessment of Heated Tobacco Product and Combustible Cigarette Aerosols in the Ames and In Vitro Micronucleus Assays

November 18, 2022

By Cole Gibson

Intention to purchase multiple e-cigarette flavors and its effect on projected use rate across tobacco user and nonuser groups

November 18, 2022

By Cole Gibson

Longitudinal Analysis on the Effect of E-cigarette Use on Cigarette Smoking Using the PATH Adult Study

November 18, 2022

By Cole Gibson

Nicotine Pharmacokinetics and Abuse Liability Assessment of Velo Oral Nicotine Pouches

November 18, 2022

By Cole Gibson

Nrf2 Responses in a 3D Human Airway Model Exposed to Whole Aerosol from Combustible Cigarettes or Heated Tobacco Products

November 18, 2022

By Cole Gibson

The Role of Flavors in Migrating Adult Smokers to Alternative Nicotine Products

November 18, 2022

By Cole Gibson

The Use of Connected Devices in Human Research

November 18, 2022

By Cole Gibson

Tobacco Harm Reduction: A Chemistry Perspective of the Risk Continuum

November 18, 2022

By Cole Gibson

A single arm, randomized cross over study in confinement to assess abuse liability and nicotine pharmacokinetics of Vuse Alto ENDS.

November 18, 2022

By Cole Gibson

Posts navigation

Older posts
Newer posts
Science Innovation Scientific Assessment Science Engagement & Communication
Our Scientists Conferences Publications

This website is intended for scientists and policymakers. We encourage persons interested in tobacco harm reduction to consider all points of view and sources of information. Reynolds does not make health claims regarding its brands. Nothing contained here should be misconstrued to the contrary. To the extent that third-party sources are referenced, Reynolds is not responsible for the content of referenced sources and the views expressed may not represent the views of Reynolds. No tobacco product is safe, all tobacco products containing nicotine are addictive. Youth should never use tobacco. Smokers who are concerned about their health should quit.
Reynolds American Inc. is the U.S. parent company of, among others, R. J. Reynolds Tobacco Company; Santa Fe Natural Tobacco Company, Inc.; American Snuff Company, LLC; R. J. Reynolds Vapor Company; Modoral Brands Inc.; RAI Services Company; and Reynolds Marketing Services Company. All subsidiaries operate and conduct separate, distinct businesses. References to “Reynolds,” “the group,” “the company,” “we,” “us,” and “our” are simply for convenience and may be used to refer to Reynolds American Inc. and/or one of its independent subsidiary operating companies, collectively or individually, and are not intended to imply or suggest that the subsidiaries’ businesses are operated other than as separate, distinct businesses. Activities among affiliate companies are covered through intercompany services agreements with arm's-length terms and conditions.

© 2025 RAISC

Terms of Use Privacy Policy